Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2IMC

Clostridium botulinum Neurotoxin Serotype A Light Chain, Residues 1-424

Summary for 2IMC
Entry DOI10.2210/pdb2imc/pdb
Related2ILP 2IMA 2IMB
DescriptorBotulinum neurotoxin A light-chain, ZINC ION (3 entities in total)
Functional Keywordsclostridium botulinum neurotoxin serotype a, protease inhibitors, substrate specificity, hydrolase
Biological sourceClostridium botulinum
Total number of polymer chains2
Total formula weight101765.36
Authors
Silvaggi, N.R.,Allen, K.N. (deposition date: 2006-10-04, release date: 2007-06-05, Last modification date: 2024-02-21)
Primary citationSilvaggi, N.R.,Boldt, G.E.,Hixon, M.S.,Kennedy, J.P.,Tzipori, S.,Janda, K.D.,Allen, K.N.
Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain Complexed with Small-Molecule Inhibitors Highlight Active-Site Flexibility.
Chem.Biol., 14:533-542, 2007
Cited by
PubMed Abstract: The potential for the use of Clostridial neurotoxins as bioweapons makes the development of small-molecule inhibitors of these deadly toxins a top priority. Recently, screening of a random hydroxamate library identified a small-molecule inhibitor of C. botulinum Neurotoxin Serotype A Light Chain (BoNT/A-LC), 4-chlorocinnamic hydroxamate, a derivative of which has been shown to have in vivo efficacy in mice and no toxicity. We describe the X-ray crystal structures of BoNT/A-LC in complexes with two potent small-molecule inhibitors. The structures of the enzyme with 4-chlorocinnamic hydroxamate or 2,4-dichlorocinnamic hydroxamate bound are compared to the structure of the enzyme complexed with L-arginine hydroxamate, an inhibitor with modest affinity. Taken together, this suite of structures provides surprising insights into the BoNT/A-LC active site, including unexpected conformational flexibility at the S1' site that changes the electrostatic environment of the binding pocket. Information gained from these structures will inform the design and optimization of more effective small-molecule inhibitors of BoNT/A-LC.
PubMed: 17524984
DOI: 10.1016/j.chembiol.2007.03.014
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

229380

PDB entries from 2024-12-25

PDB statisticsPDBj update infoContact PDBjnumon